This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,418.92, is a delivery order for the supply of the specialty medication Dupixent 300 mg/2 ml pen. The contract has a completion date of December 9, 2024 and is a firm fixed-price contract. Amerisourcebergen is a for-profit organization and a registered vendor in the System for Award Management (SAM.gov). The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/7/25, 9:52 AM